PES Drugs and Therapeutics Committee presents a statement on the Risk of Prolonged QT Interval with Gonadotropin Releasing Hormone Agonists.
Read MoreAn International Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children.
Read MoreA Study From the Pediatric Research in Office Settings Network describing Secondary Sexual Characteristics and Menses in Young Girls.
Read More